Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5658346 | Gastroenterology | 2017 | 11 Pages |
Abstract
Hereditary mixed polyposis syndrome is a rare colon cancer predisposition syndrome caused by a duplication of a noncoding sequence near the gremlin 1, DAN family BMP antagonist gene (GREM1) originally described in Ashkenazi Jews. Few families with GREM1 duplications have been described, so there are many questions about detection and management. We report 4 extended families with the duplication near GREM1 previously found in Ashkenazi Jews; 3 families were identified at cancer genetic clinics in Israel and 1 family was identified in a cohort of patients with familial colorectal cancer. Their clinical features include extracolonic tumors, onset of polyps in adolescence, and rapid progression of some polyps to advanced adenomas. One family met diagnostic criteria for Lynch syndrome. Expansion of the hereditary mixed polyposis syndrome phenotype can inform surveillance strategies for carriers of GREM1 duplications.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Sari Lieberman, Tom Walsh, Menachem Schechter, Tomer Adar, Eran Goldin, Rachel Beeri, Nitzan Sharon, Hagit Baris, Liat Ben Avi, Elizabeth Half, Israela Lerer, Brian H. Shirts, Colin C. Pritchard, Ian Tomlinson, Mary-Claire King, Ephrat Levy-Lahad,